Generalized anxiety disorder (GAD) is a common and disabling illness that is often
underdiagnosed and undertreated. Patients with GAD are at increased risk for suicide as …

Background Generalised anxiety disorder is a disease that can be associated with
substantial dysfunction. Pharmacological treatment is often the first choice for clinicians …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Objective: To provide practical clinical guidance for the treatment of adults with panic
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …

Generalized anxiety disorder (GAD) and panic disorder (PD) are among the most common
mental disorders in the United States, and they can negatively impact a patient's quality of …

Background: Treatment resistance is a significant problem among young people
experiencing moderate-to-severe anxiety, affecting nearly half of all patients. This study …

Optogenetic tools have provided a new way to establish causal relationships between brain
activity and behaviour in health and disease. Although no animal model captures human …

Objective Inflammation has been implicated in the aetiology of mental illness. We conducted
the first systematic review and meta-analysis of the association between peripheral markers …

This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

Introduction: The first two alpha2delta ligands–gabapentin (GBP) and pregabalin (PGB)–
were initially synthesized as antiepileptics; however, they were later also found to be useful …